Tesamorelin

$80.00

Availability: In Stock

Tesamorelin, an analogue of growth hormone releasing
hormone (GHRH), mirrors the structure of standard GHRH,
enhanced by the addition of an extra trans-3-hexanoic acid
group. Developed by Theratechnologies in Canada,
Tesamorelin earned FDA approval in 2010 as the latest
drug for managing HIV-associated lipodystrophy. Beyond
its approved use, the peptide has undergone exploration
regarding its potential to enhance peripheral nerve
regeneration and as a potential intervention for mild
cognitive impairment (MCI), which precedes dementia.

Category:

Description

thout mannitol) This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL
ONLY. This designation allows the use of research chemicals
strictly for in vitro testing and laboratory experimentation only.
All product information available on this website is for
educational purposes only. Bodily introduction of any kind into
humans or animals is strictly forbidden by law. This product
should only be handled by licensed, qualified professionals.
This product is not a drug, food, or cosmetic and may not be
misbranded, misused or mislabeled as a drug, food, or
cosmetic.
Tesamorelin Structure
Sequence (Single Letter): Unk-Tyr-Ala-Asp-Ala-lle-Phe-ThrAsn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-LysLeu-Leu-Gln-Asp-lle-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-AsnGln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu
Molecular Formula: C223H370N72O69S
Molecular Weight: 5195.908 g/mol
PubChem CID: 44147413
CAS Number: 901758-09-6

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin”

Your email address will not be published. Required fields are marked *

Related products